RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

IMO, a succesful drug candidate passing phase 3 human clinicals that can replace the awful impact of opioids for pain management is worth billions easily. Getting to that point takes funding and resources of a BP, so RSPI would give up majority of equity in that asset. Since their filings indicate many insiders are looking for a payment event to trigger equity compensatio, then I would expect a partnership with cash and milestone type payments. Whether BP wants to deal with OTC shenanagins, is another story. Maybe a buyout would be more desireable, but value increases exponentially with each passing of human clincals, phase 1,2,3...Maybe RSPI uplists to a higher exchange to pursue their other drug programs in the works.

All speculation of course but I think minimum dimes and quarters are possible with a BP deal. Makes the risk v. reward extremely attractive here.